{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:42:32Z","timestamp":1781332952050,"version":"3.54.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T00:00:00Z","timestamp":1517961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","award":["PS ID 32387"],"award-info":[{"award-number":["PS ID 32387"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1120816N"],"award-info":[{"award-number":["1120816N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s10096-017-3179-1","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T09:45:13Z","timestamp":1517996713000},"page":"859-869","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Human papillomavirus genotype and viral load agreement between paired first-void urine and clinician-collected cervical samples"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1842-7478","authenticated-orcid":false,"given":"Severien","family":"Van Keer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebren A. A.","family":"Tjalma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Pattyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Biesmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zo\u00eb","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xaveer","family":"Van Ostade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Ieven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Vorsters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,7]]},"reference":[{"key":"3179_CR1","unstructured":"GLOBOCAN (2012) Cervical cancer: estimated incidence, mortality and prevalence worldwide in 2012. http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx . Accessed 1 Sept 2017"},{"issue":"6","key":"3179_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.vaccine.2015.12.063","volume":"34","author":"P Damme Van","year":"2016","unstructured":"Van Damme P, Bonanni P, Bosch FX, Joura E, Kjaer SK, Meijer CJ, Petry KU, Soubeyrand B, Verstraeten T, Stanley M (2016) Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines. Vaccine 34(6):757\u2013761. https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.063","journal-title":"Vaccine"},{"issue":"7","key":"3179_CR3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S1470-2045(15)00047-9","volume":"16","author":"AR Kreimer","year":"2015","unstructured":"Kreimer AR, Struyf F, Del Rosario-Raymundo MR, Hildesheim A, Skinner SR, Wacholder S, Garland SM, Herrero R, David MP, Wheeler CM, Costa Rica Vaccine Trial Study Group A, Gonzalez P, Jimenez S, Lowy DR, Pinto LA, Porras C, Rodriguez AC, Safaeian M, Schiffman M, Schiller JT, Schussler J, Sherman ME, Authors PSG, Bosch FX, Castellsague X, Chatterjee A, Chow SN, Descamps D, Diaz-Mitoma F, Dubin G, Germar MJ, Harper DM, Lewis DJ, Limson G, Naud P, Peters K, Poppe WA, Ramjattan B, Romanowski B, Salmeron J, Schwarz TF, Teixeira JC, Tjalma WA, Collaborators HPPIC-PI, Group GSKVCSS (2015) Efficacy of fewer than three doses of an HPV-16\/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica vaccine and PATRICIA trials. Lancet Oncol 16(7):775\u2013786. https:\/\/doi.org\/10.1016\/S1470-2045(15)00047-9","journal-title":"Lancet Oncol"},{"key":"3179_CR4","doi-asserted-by":"publisher","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","volume":"30","author":"M Arbyn","year":"2012","unstructured":"Arbyn M, Ronco G, Anttila A, Meijer CJLM, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J (2012) Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 30:F88\u2013F99. https:\/\/doi.org\/10.1016\/j.vaccine.2012.06.095","journal-title":"Vaccine"},{"issue":"9916","key":"3179_CR5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco G, Dillner J, Elfstrom KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P, Berkhof J, Peto J, Meijer CJ, International HPVswg (2014) Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 383(9916):524\u2013532. https:\/\/doi.org\/10.1016\/S0140-6736(13)62218-7","journal-title":"Lancet"},{"key":"3179_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2017.06.036","volume":"216","author":"S Keer Van","year":"2017","unstructured":"Van Keer S, Pattyn J, Tjalma WAA, Van Ostade X, Ieven M, Van Damme P, Vorsters A (2017) First-void urine: a potential biomarker source for triage of high-risk human papillomavirus infected women. Eur J Obstet Gynecol Reprod Biol 216:1\u201311. https:\/\/doi.org\/10.1016\/j.ejogrb.2017.06.036","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"3179_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1258\/jms.2009.009073","volume":"16","author":"J Waller","year":"2009","unstructured":"Waller J, Bartoszek M, Marlow L, Wardle J (2009) Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen 16(4):199\u2013204. https:\/\/doi.org\/10.1258\/jms.2009.009073","journal-title":"J Med Screen"},{"key":"3179_CR8","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s12889-016-3474-2","volume":"16","author":"S Arrossi","year":"2016","unstructured":"Arrossi S, Ramos S, Straw C, Thouyaret L, Orellana L (2016) HPV testing: a mixed-method approach to understand why women prefer self-collection in a middle-income country. BMC Public Health 16:832. https:\/\/doi.org\/10.1186\/s12889-016-3474-2","journal-title":"BMC Public Health"},{"issue":"2","key":"3179_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","volume":"15","author":"M Arbyn","year":"2014","unstructured":"Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, Minozzi S, Bellisario C, Banzi R, Zhao FH, Hillemanns P, Anttila A (2014) Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 15(2):172\u2013183. https:\/\/doi.org\/10.1016\/S1470-2045(13)70570-9","journal-title":"Lancet Oncol"},{"key":"3179_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pvr.2015.06.006","volume":"1","author":"L Karsa von","year":"2015","unstructured":"von Karsa L, Arbyn M, De Vuyst H, Dillner J, Dillner L, Franceschi S, Patnick J, Ronco G, Segnan N, Suonio E, T\u00f6rnberg S, Anttila A (2015) European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination. Papillomavirus Res 1:22\u201331. https:\/\/doi.org\/10.1016\/j.pvr.2015.06.006","journal-title":"Papillomavirus Res"},{"issue":"1","key":"3179_CR11","doi-asserted-by":"publisher","first-page":"E44","DOI":"10.1111\/1469-0691.12063","volume":"19","author":"C Tamalet","year":"2013","unstructured":"Tamalet C, Le Retraite L, Leandri FX, Heid P, Sancho Garnier H, Piana L (2013) Vaginal self-sampling is an adequate means of screening HR-HPV types in women not participating in regular cervical cancer screening. Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis 19(1):E44\u2013E50. https:\/\/doi.org\/10.1111\/1469-0691.12063","journal-title":"Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"2","key":"3179_CR12","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1007\/BF03405681","volume":"104","author":"CS Racey","year":"2013","unstructured":"Racey CS, Withrow DR, Gesink D (2013) Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis. Can J Publ Health Rev Can Sante Publique 104(2):e159\u2013e166","journal-title":"Can J Publ Health Rev Can Sante Publique"},{"issue":"16","key":"3179_CR13","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.ejca.2015.07.006","volume":"51","author":"F Verdoodt","year":"2015","unstructured":"Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJ, Arbyn M (2015) Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer 51(16):2375\u20132385. https:\/\/doi.org\/10.1016\/j.ejca.2015.07.006","journal-title":"Eur J Cancer"},{"issue":"3","key":"3179_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jinf.2015.05.001","volume":"71","author":"A Ducancelle","year":"2015","unstructured":"Ducancelle A, Reiser J, Pivert A, Le Guillou-Guillemette H, Le Duc-Banaszuk AS, Lunel-Fabiani F (2015) Home-based urinary HPV DNA testing in women who do not attend cervical cancer screening clinics. J Infect 71(3):377\u2013384. https:\/\/doi.org\/10.1016\/j.jinf.2015.05.001","journal-title":"J Infect"},{"issue":"5","key":"3179_CR15","first-page":"513","volume":"163","author":"JW Sellors","year":"2000","unstructured":"Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P, Howard M, Chong S, Daya D, Chapman W, Chernesky M (2000) Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ 163(5):513\u2013518","journal-title":"CMAJ"},{"key":"3179_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jcv.2015.11.005","volume":"74","author":"V Senkomago","year":"2016","unstructured":"Senkomago V, Des Marais AC, Rahangdale L, Vibat CR, Erlander MG, Smith JS (2016) Comparison of urine specimen collection times and testing fractions for the detection of high-risk human papillomavirus and high-grade cervical precancer. J Clin Virol 74:26\u201331. https:\/\/doi.org\/10.1016\/j.jcv.2015.11.005","journal-title":"J Clin Virol"},{"key":"3179_CR17","doi-asserted-by":"publisher","unstructured":"Leeman A, Del Pino M, Molijn A, Rodriguez A, Torne A, de Koning M, Ordi J, van Kemenade F, Jenkins D, Quint W (2017) HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable to a physician-taken smear or brush-based self-sample: cross-sectional data from a triage population. BJOG: Int J Obstet Gynaecol 124(9):1356\u20131363. https:\/\/doi.org\/10.1111\/1471-0528.14682","DOI":"10.1111\/1471-0528.14682"},{"issue":"3","key":"3179_CR18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/jmv.24085","volume":"87","author":"E Burroni","year":"2015","unstructured":"Burroni E, Bonanni P, Sani C, Lastrucci V, Carozzi F, Hpv ScreeVacc Working G, Iossa A, Andersson KL, Brandigi L, Di Pierro C, Confortini M, Levi M, Boccalini S, Indiani L, Sala A, Tanini T, Bechini A, Azzari C (2015) Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening. J Med Virol 87(3):508\u2013515. https:\/\/doi.org\/10.1002\/jmv.24085","journal-title":"J Med Virol"},{"issue":"9","key":"3179_CR19","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1158\/1940-6207.CAPR-16-0038","volume":"9","author":"AL Combita","year":"2016","unstructured":"Combita AL, Gheit T, Gonzalez P, Puerto D, Murillo RH, Montoya L, Vorsters A, Van Keer S, Van Damme P, Tommasino M, Hernandez-Suarez G, Sanchez L, Herrero R, Wiesner C (2016) Comparison between urine and cervical samples for HPV DNA detection and typing in young women in Colombia. Cancer Prev Res (Phila) 9(9):766\u2013771. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-16-0038","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"3179_CR20","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/ijc.30092","volume":"139","author":"S Franceschi","year":"2016","unstructured":"Franceschi S, Chantal Umulisa M, Tshomo U, Gheit T, Baussano I, Tenet V, Tshokey T, Gatera M, Ngabo F, Van Damme P, Snijders PJ, Tommasino M, Vorsters A, Clifford GM (2016) Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda. Int J Cancer 139(3):518\u2013526. https:\/\/doi.org\/10.1002\/ijc.30092","journal-title":"Int J Cancer"},{"issue":"5","key":"3179_CR21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10096-011-1358-z","volume":"31","author":"A Vorsters","year":"2012","unstructured":"Vorsters A, Micalessi I, Bilcke J, Ieven M, Bogers J, Van Damme P (2012) Detection of human papillomavirus DNA in urine. A review of the literature. Eur J Clin Microbiol Infect Dis 31(5):627\u2013640. https:\/\/doi.org\/10.1007\/s10096-011-1358-z","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3179_CR22","doi-asserted-by":"publisher","unstructured":"Vorsters A, Van Keer S, Biesmans S, Hens A, De Coster I, Goossens H, Ieven M, Van Damme P (2016) Long-term follow-up of HPV infection using urine and cervical quantitative HPV DNA testing. Int J Mol Sci 17(5). https:\/\/doi.org\/10.3390\/ijms17050750","DOI":"10.3390\/ijms17050750"},{"issue":"2","key":"3179_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00404-014-3191-y","volume":"290","author":"A Ducancelle","year":"2014","unstructured":"Ducancelle A, Legrand MC, Pivert A, Veillon P, Le Guillou-Guillemette H, De Brux MA, Beby-Defaux A, Agius G, Hantz S, Alain S, Catala L, Descamps P, Postec E, Caly H, Charles-Petillon F, Labrousse F, Lunel F, Payan C (2014) Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions. Arch Gynecol Obstet 290(2):299\u2013308. https:\/\/doi.org\/10.1007\/s00404-014-3191-y","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"3179_CR24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1128\/JCM.02022-06","volume":"45","author":"C Payan","year":"2007","unstructured":"Payan C, Ducancelle A, Aboubaker MH, Caer J, Tapia M, Chauvin A, Peyronnet D, Le Hen E, Arab Z, Legrand MC, Tran A, Postec E, Tourmen F, Avenel M, Malbois C, De Brux MA, Descamps P, Lunel F (2007) Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems. J Clin Microbiol 45(3):897\u2013901. https:\/\/doi.org\/10.1128\/JCM.02022-06","journal-title":"J Clin Microbiol"},{"key":"3179_CR25","doi-asserted-by":"publisher","first-page":"g5264","DOI":"10.1136\/bmj.g5264","volume":"349","author":"N Pathak","year":"2014","unstructured":"Pathak N, Dodds J, Zamora J, Khan K (2014) Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis. BMJ 349:g5264. https:\/\/doi.org\/10.1136\/bmj.g5264","journal-title":"BMJ"},{"key":"3179_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/CLEP.S39799","volume":"5","author":"E Enerly","year":"2013","unstructured":"Enerly E, Olofsson C, Nygard M (2013) Monitoring human papillomavirus prevalence in urine samples: a review. Clin Epidemiol 5:67\u201379. https:\/\/doi.org\/10.2147\/CLEP.S39799","journal-title":"Clin Epidemiol"},{"issue":"8","key":"3179_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jiac.2016.05.009","volume":"22","author":"M Hagihara","year":"2016","unstructured":"Hagihara M, Yamagishi Y, Izumi K, Miyazaki N, Suzuki T, Kato H, Nishiyama N, Koizumi Y, Suematsu H, Mikamo H (2016) Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus. J Infect Chemother: Off J Jpn Soc Chemother 22(8):559\u2013562. https:\/\/doi.org\/10.1016\/j.jiac.2016.05.009","journal-title":"J Infect Chemother: Off J Jpn Soc Chemother"},{"issue":"1","key":"3179_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1128\/JCM.01623-13","volume":"52","author":"VV Sahasrabuddhe","year":"2014","unstructured":"Sahasrabuddhe VV, Gravitt PE, Dunn ST, Brown D, Allen RA, Eby YJ, Smith K, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N (2014) Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. J Clin Microbiol 52(1):187\u2013192. https:\/\/doi.org\/10.1128\/jcm.01623-13","journal-title":"J Clin Microbiol"},{"key":"3179_CR29","doi-asserted-by":"publisher","first-page":"g6252","DOI":"10.1136\/bmj.g6252","volume":"349","author":"A Vorsters","year":"2014","unstructured":"Vorsters A, Van Damme P, Clifford G (2014) Urine testing for HPV: rationale for using first void. BMJ 349:g6252. https:\/\/doi.org\/10.1136\/bmj.g6252","journal-title":"BMJ"},{"key":"3179_CR30","unstructured":"Smith JS, Smith JB, Faherty BR, Isaacson SC, Des Marais AC, Fakner A, Rahangdale L, Vaughan LM (2017) Effect of urine preservative on HPV testing results among urine samples. In: HPV2017, Cape Town, South Africa"},{"issue":"11","key":"3179_CR31","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s10096-014-2147-2","volume":"33","author":"A Vorsters","year":"2014","unstructured":"Vorsters A, Van den Bergh J, Micalessi I, Biesmans S, Bogers J, Hens A, De Coster I, Ieven M, Van Damme P (2014) Optimization of HPV DNA detection in urine by improving collection, storage, and extraction. Eur J Clin Microbiol Infect Dis 33(11):2005\u20132014. https:\/\/doi.org\/10.1007\/s10096-014-2147-2","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"3179_CR32","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1128\/JCM.00087-13","volume":"51","author":"M Schmitt","year":"2013","unstructured":"Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M, Group VS (2013) Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. J Clin Microbiol 51(5):1458\u20131464. https:\/\/doi.org\/10.1128\/JCM.00087-13","journal-title":"J Clin Microbiol"},{"issue":"3","key":"3179_CR33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/jmv.24645","volume":"89","author":"Z Wu","year":"2017","unstructured":"Wu Z, Qin Y, Yu L, Lin C, Wang H, Cui J, Liu B, Liao Y, Warren D, Zhang X, Chen W (2017) Association between human papillomavirus (HPV) 16, HPV18, and other HR-HPV viral load and the histological classification of cervical lesions: results from a large-scale cross-sectional study. J Med Virol 89(3):535\u2013541. https:\/\/doi.org\/10.1002\/jmv.24645","journal-title":"J Med Virol"},{"issue":"2","key":"3179_CR34","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/jmv.23190","volume":"84","author":"X Carcopino","year":"2012","unstructured":"Carcopino X, Henry M, Mancini J, Giusiano S, Boubli L, Olive D, Tamalet C (2012) Significance of HPV 16 and 18 viral load quantitation in women referred for colposcopy. J Med Virol 84(2):306\u2013313. https:\/\/doi.org\/10.1002\/jmv.23190","journal-title":"J Med Virol"},{"key":"3179_CR35","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/1471-2407-14-384","volume":"14","author":"L Marongiu","year":"2014","unstructured":"Marongiu L, Godi A, Parry JV, Beddows S (2014) Human papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage. BMC Cancer 14:384. https:\/\/doi.org\/10.1186\/1471-2407-14-384","journal-title":"BMC Cancer"},{"issue":"8","key":"3179_CR36","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1002\/cam4.473","volume":"4","author":"CE Depuydt","year":"2015","unstructured":"Depuydt CE, Jonckheere J, Berth M, Salembier GM, Vereecken AJ, Bogers JJ (2015) Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections. Cancer Med 4(8):1294\u20131302. https:\/\/doi.org\/10.1002\/cam4.473","journal-title":"Cancer Med"},{"issue":"12","key":"3179_CR37","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1111\/j.1582-4934.2012.01631.x","volume":"16","author":"CE Depuydt","year":"2012","unstructured":"Depuydt CE, Criel AM, Benoy IH, Arbyn M, Vereecken AJ, Bogers JJ (2012) Changes in type-specific human papillomavirus load predict progression to cervical cancer. J Cell Mol Med 16(12):3096\u20133104. https:\/\/doi.org\/10.1111\/j.1582-4934.2012.01631.x","journal-title":"J Cell Mol Med"},{"issue":"10","key":"3179_CR38","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1002\/jmv.22167","volume":"83","author":"SL Bissett","year":"2011","unstructured":"Bissett SL, Howell-Jones R, Swift C, De Silva N, Biscornet L, Parry JV, Saunders NA, Nathan M, Soldan K, Szarewski A, Cuzick J, Beddows S (2011) Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males. J Med Virol 83(10):1744\u20131751. https:\/\/doi.org\/10.1002\/jmv.22167","journal-title":"J Med Virol"},{"key":"3179_CR39","doi-asserted-by":"publisher","unstructured":"Sehgal A, Gupta S, Parashari A, Sodhani P, Singh V (2009) Urine HPV-DNA detection for cervical cancer screening: prospects and prejudices. J Inst Obstet Gynaecol 29(7):583\u2013589. https:\/\/doi.org\/10.1080\/01443610903061736","DOI":"10.1080\/01443610903061736"},{"key":"3179_CR40","unstructured":"IARC (2016) Agents classified by the IARC Monographs. vol 1\u2013120. http:\/\/monographs.iarc.fr\/ENG\/Classification\/latest_classif.php . Accessed 27 Oct. 2017"},{"issue":"9","key":"3179_CR41","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/ijc.30238","volume":"139","author":"CE Depuydt","year":"2016","unstructured":"Depuydt CE, Thys S, Beert J, Jonckheere J, Salembier G, Bogers JJ (2016) Linear viral load increase of a single HPV-type in women with multiple HPV infections predicts progression to cervical cancer. Int J Cancer 139(9):2021\u20132032. https:\/\/doi.org\/10.1002\/ijc.30238","journal-title":"Int J Cancer"},{"issue":"4","key":"3179_CR42","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1515\/cclm.2011.835","volume":"50","author":"IM Micalessi","year":"2012","unstructured":"Micalessi IM, Boulet GAV, Bogers JJ, Benoy IH, Depuydt CE (2012) High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR. Clin Chem Lab Med 50(4):655\u2013661. https:\/\/doi.org\/10.1515\/Cclm.2011.835","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"3179_CR43","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1128\/JCM.01231-12","volume":"50","author":"CE Depuydt","year":"2012","unstructured":"Depuydt CE, Benoy IH, Beert JF, Criel AM, Bogers JJ, Arbyn M (2012) Clinical validation of a type-specific real-time quantitative human papillomavirus PCR against the performance of hybrid capture 2 for the purpose of cervical cancer screening. J Clin Microbiol 50(12):4073\u20134077. https:\/\/doi.org\/10.1128\/JCM.01231-12","journal-title":"J Clin Microbiol"},{"key":"3179_CR44","unstructured":"Pattyn J, Dekoeijer, Van Keer S, Biesmans S, Ieven M, Beyers K, Vankerckhoven V, Van Damme P, Vorsters A (2017) HPV DNA detection in urine: effect of a first-void urine collection device and timing of collection. In: HPV2017, Cape Town, South Africa"},{"issue":"1","key":"3179_CR45","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/biostatistics\/1.1.113","volume":"1","author":"S Greenland","year":"2000","unstructured":"Greenland S (2000) Small-sample bias and corrections for conditional maximum-likelihood odds-ratio estimators. Biostatistics 1(1):113\u2013122. https:\/\/doi.org\/10.1093\/biostatistics\/1.1.113","journal-title":"Biostatistics"},{"key":"3179_CR46","unstructured":"Klaus B, Strimmer K (2015) fdrtool: estimation of (local) false discovery rates and higher criticism. R package version 1.2.15. http:\/\/CRAN.R-project.org\/package=fdrtool"},{"key":"3179_CR47","unstructured":"Team RC (2017) R: A Language and Environment for Statistical Computing. https:\/\/www.r-project.org\/"},{"key":"3179_CR48","doi-asserted-by":"crossref","unstructured":"Altman DG (1991) Practical statistics for medical research. Chapman and Hall\/CRC","DOI":"10.1201\/9780429258589"},{"issue":"4","key":"3179_CR49","doi-asserted-by":"publisher","first-page":"e010660","DOI":"10.1136\/bmjopen-2015-010660","volume":"6","author":"G Stanczuk","year":"2016","unstructured":"Stanczuk G, Baxter G, Currie H, Lawrence J, Cuschieri K, Wilson A, Arbyn M (2016) Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the papillomavirus Dumfries and Galloway-PaVDaG study). BMJ Open 6(4):e010660. https:\/\/doi.org\/10.1136\/bmjopen-2015-010660","journal-title":"BMJ Open"},{"issue":"1","key":"3179_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12985-017-0744-2","volume":"14","author":"U Tshomo","year":"2017","unstructured":"Tshomo U, Franceschi S, Tshokey T, Tobgay T, Baussano I, Tenet V, Snijders PJ, Gheit T, Tommasino M, Vorsters A, Clifford GM (2017) Evaluation of the performance of human papillomavirus testing in paired urine and clinician-collected cervical samples among women aged over 30 years in Bhutan. Virol J 14(1):74. https:\/\/doi.org\/10.1186\/s12985-017-0744-2","journal-title":"Virol J"},{"issue":"7","key":"3179_CR51","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1158\/1055-9965.EPI-16-0960","volume":"26","author":"J Cuzick","year":"2017","unstructured":"Cuzick J, Cadman L, Ahmad AS, Ho L, Terry G, Kleeman M, Lyons D, Austin J, Stoler MH, Vibat CRT, Dockter J, Robbins D, Billings PR, Erlander MG (2017) Performance and diagnostic accuracy of a urine-based human papillomavirus assay in a referral population. Cancer Epidemiol Biomark Prev: Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 26(7):1053\u20131059. https:\/\/doi.org\/10.1158\/1055-9965.EPI-16-0960","journal-title":"Cancer Epidemiol Biomark Prev: Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"issue":"3","key":"3179_CR52","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4103\/0019-509X.52952","volume":"46","author":"KW D\u2019Hauwers","year":"2009","unstructured":"D\u2019Hauwers KW, Tjalma WA (2009) Screening for human papillomavirus: is urine useful? Indian J Cancer 46(3):190\u2013193. https:\/\/doi.org\/10.4103\/0019-509x.52952","journal-title":"Indian J Cancer"},{"key":"3179_CR53","unstructured":"ICO (2017) Human papillomavirus and related disease report. http:\/\/www.hpvcentre.net\/statistics\/reports\/XWX.pdf . Accessed 1 Sept 2017"},{"issue":"2","key":"3179_CR54","first-page":"101","volume":"7","author":"WA Tjalma","year":"2015","unstructured":"Tjalma WA, Trinh XB, Rosenlund M, Makar AP, Kridelka F, Rosillon D, Van Dam PA, Collas De Souza S, Holl K, Simon P, Jenkins D (2015) A cross-sectional, multicentre, epidemiological study on human papillomavirus (HPV) type distribution in adult women diagnosed with invasive cervical cancer in Belgium. Facts Views Vis Obgyn 7(2):101\u2013108","journal-title":"Facts Views Vis Obgyn"},{"issue":"4","key":"3179_CR55","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ijc.27713","volume":"132","author":"WA Tjalma","year":"2013","unstructured":"Tjalma WA, Fiander A, Reich O, Powell N, Nowakowski AM, Kirschner B, Koiss R, O\u2019Leary J, Joura EA, Rosenlund M, Colau B, Schledermann D, Kukk K, Damaskou V, Repanti M, Vladareanu R, Kolomiets L, Savicheva A, Shipitsyna E, Ordi J, Molijn A, Quint W, Raillard A, Rosillon D, De Souza SC, Jenkins D, Holl K (2013) Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer 132(4):854\u2013867. https:\/\/doi.org\/10.1002\/ijc.27713","journal-title":"Int J Cancer"},{"issue":"2","key":"3179_CR56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/LGT.0000000000000081","volume":"19","author":"E Chamot","year":"2015","unstructured":"Chamot E, Mulambia C, Kapambwe S, Shrestha S, Parham GP, Macwan\u2019gi M, Mwanahamuntu MH (2015) Preference for human papillomavirus-based cervical cancer screening: results of a choice-based conjoint study in Zambia. J Low Genit Tract Dis 19(2):119\u2013123. https:\/\/doi.org\/10.1097\/LGT.0000000000000081","journal-title":"J Low Genit Tract Dis"},{"issue":"2","key":"3179_CR57","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4161\/21645515.2014.995058","volume":"11","author":"A Vorsters","year":"2015","unstructured":"Vorsters A, Van Keer S, Van Damme P (2015) The use of urine in the follow-up of HPV vaccine trials. Hum Vacc Immunother 11(2):350\u2013352. https:\/\/doi.org\/10.4161\/21645515.2014.995058","journal-title":"Hum Vacc Immunother"},{"issue":"11","key":"3179_CR58","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1002\/jmv.22183","volume":"83","author":"K Cuschieri","year":"2011","unstructured":"Cuschieri K, Nandwani R, McGough P, Cook F, Hogg L, Robertson C, Cubie H (2011) Urine testing as a surveillance tool to monitor the impact of HPV immunization programs. J Med Virol 83(11):1983\u20131987. https:\/\/doi.org\/10.1002\/jmv.22183","journal-title":"J Med Virol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-017-3179-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-017-3179-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-017-3179-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T20:12:04Z","timestamp":1603829524000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-017-3179-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,7]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["3179"],"URL":"https:\/\/doi.org\/10.1007\/s10096-017-3179-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,7]]},"assertion":[{"value":"30 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"P. Van Damme and A. Vorsters are co-founders of Novosanis (Belgium), a spin-off company of the University of Antwerp. All other authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee (UZA\/University of Antwerp, Belgium (B300201525585)) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}